PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 51 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $318,000 | -70.7% | 1,808,098 | 0.0% | 0.00% | – |
| Q2 2022 | $1,085,000 | -55.0% | 1,808,098 | -1.0% | 0.00% | – |
| Q1 2022 | $2,410,000 | -49.7% | 1,826,131 | -0.5% | 0.00% | – |
| Q4 2021 | $4,789,000 | -17.8% | 1,834,903 | -2.1% | 0.00% | – |
| Q3 2021 | $5,829,000 | -16.1% | 1,874,573 | +0.3% | 0.00% | – |
| Q2 2021 | $6,951,000 | +27.8% | 1,868,664 | +18.9% | 0.00% | – |
| Q1 2021 | $5,438,000 | +112.4% | 1,571,586 | +106.3% | 0.00% | – |
| Q4 2020 | $2,560,000 | +0.1% | 761,927 | +4.6% | 0.00% | – |
| Q3 2020 | $2,557,000 | -24.7% | 728,678 | -1.2% | 0.00% | – |
| Q2 2020 | $3,394,000 | +38.9% | 737,853 | -0.1% | 0.00% | – |
| Q1 2020 | $2,444,000 | -46.0% | 738,678 | -0.3% | 0.00% | – |
| Q4 2019 | $4,528,000 | +46.0% | 741,139 | -0.3% | 0.00% | – |
| Q3 2019 | $3,101,000 | -64.9% | 743,633 | +10.4% | 0.00% | – |
| Q2 2019 | $8,838,000 | +405.0% | 673,620 | +266.1% | 0.00% | – |
| Q1 2019 | $1,750,000 | +221.7% | 183,994 | +4.5% | 0.00% | – |
| Q4 2018 | $544,000 | – | 175,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |